Author:
Halenka Milan,Fryšák Zdeněk
Publisher
Springer International Publishing
Reference15 articles.
1. Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–58.
2. Bilezikian JP, Khan AA, Potts Jr JT, Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–9.
3. Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart Jr P, Ferraz AR. Parathyroid carcinoma. Am J Surg. 1998;175(1):52–5.
4. Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, et al. Strategy of operative treatment of hyperparathyroidism using US scan and (99m)Tc-MIBI SPECT/CT. Endocr J. 2014;61(3):225–30.
5. Akbaba G, Berker D, Isik S, Aydin Y, Ciliz D, Peksoy I, et al. A comparative study of pre-operative imaging methods in patients with primary hyperparathyroidism: ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging. J Endocrinol Investig. 2012;35(4):359–64.